 |
Assessment Tools and Guidelines: Parenteral Nutrition Therapy
Malnutrition is associated with
an increased frequency of
treatment complications
and length of stay in the intensive
care unit (ICU) and hospital, as well
as increased costs of medical care.
Patients at high risk for malnutrition
should be identified and evaluated for
specialized nutrition support (SNS).
JULY, 2010 |
 |
Updates in the Diagnosis and Treatment of Mycosis Fungoides and Sézary Syndrome
MF is highly symptomatic and progressive, with
poor prognosis at later stages. When MF is grouped
by stage, patients with patch-plaque disease (stages
IA, IB, and IIA) have a survival of more than 12 years
and those with tumors or erythroderma (stages IIB/III)
have a median survival of approximately 4 years; however,
those with stage IV, which includes patients with
lymph node or visceral involvement, have a median
survival of less than 3 years. Similarly, patients with
SS have a median survival of less than 3 years.
JUNE, 2010 |
 |
Chemotherapy-Induced Nausea and Vomiting
Guideline Summary and Clinical Challenges
Chemotherapy-induced nausea and vomiting (CINV) can significantly impact patient care and quality of life (QoL), resulting in potential complications of electrolyte disturbances, decreased functional ability, weight loss, anorexia, esophageal tears, and treatment noncompliance.
MAY, 2010 |
 |
Management of Epidermal Growth Factor Receptor Inhibitor-Induced Dermatologic Toxicity
The epidermal growth factor receptor (EGFR) is 1 of 4 types of
human epidermal receptors that are found primarily on cells
of epithelial origin and have a vital role in cellular growth,
proliferation, and migration.1-3 Abnormal activity at the EGFR receptor
has been implicated in many types of solid tumors, including colorectal,
non-small cell lung, head and neck, and pancreatic cancers.
APRIL, 2010 |
 |
Guidelines for the Prevention of Medication Errors
The prevention of medication errors is an essential
requirement for pharmaceutical care and must be a
core mission of every pharmacy. For medication error
prevention efforts to be effective, they must become a priority.
APRIL, 2010 |
 |
Safe Handling Of Hazardous Drugs: Reviewing Standards for Worker Protection
As a new generation of health care workers joins those already engaged in patient care, it is essential that they understand the occupational risks associated with the handling of hazardous drugs. Luci Power, MS, RPh, and Martha Polovich, MN, RN, AOCN, offer the latest updates to safe handling guidelines, and offer several strategies for reducing the risks of occupational exposure.
MARCH, 2010 |
 |
Antifungal Prophylaxis in High-Risk Oncology Patients
Invasive fungal infections are a
cause of considerable morbidity
and mortality in patients with cancer. However, difficulty in establishing the
diagnosis often results in delayed antifungal therapy, which adversely impacts
survival. Prevention of invasive fungal infections is thus an appealing target
for clinical and research efforts.
FEBRUARY, 2010 |
 |
The Bone Continuum of Cancer: Early to Advanced Stage Disease
It is estimated that nearly 1.5 million people will be diagnosed with cancer
in the United States in 2009. Survival rates of many cancers are improving,
leading to an emerging population of individuals living with cancer.
FEBRUARY, 2010 |
|
1